MERGER AND ACQUISITION (Details) - Lobesity Acquisition - USD ($) $ in Millions		12 Months Ended
	Jul. 19, 2021	Dec. 31, 2021
Business Acquisition [Line Items]
Cash consideration	$ 2.3	$ 2.3
Common stock consideration (in shares)	120,861
Regulatory and clinical milestone payments	$ 45.5
Number of shares subject to restrictions (in shares)	30,216
Restriction period	18 months
Value of common stock acquired		2.6
Transaction cost		$ 0.2
Maximum
Business Acquisition [Line Items]
Regulatory and clinical milestone payments	$ 58.0
Sales related milestone payments	$ 50.0